Amerisource Health Services LLC 2025-11-05 Health serious FDA
Health · FDA · Recall #FDA-D-0103-2026
Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only,… Recall
Issued November 5, 2025 · Amerisource Health Services LLC
In November 2025, Amerisource Health Services LLC recalled the Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only,…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
What you should do
- 1 Stop using Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Amerisource Health Services LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Amerisource Health Services LLC
- Category
- Health
- Recall date
- November 5, 2025
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-0103-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Amerisource Health Services LLC has 20 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.